|
MX2020011386A
(es)
|
2018-04-27 |
2021-01-29 |
Spacecraft Seven Llc |
Terapia genica para la degeneracion del snc.
|
|
CN113966399A
(zh)
|
2018-09-26 |
2022-01-21 |
加州理工学院 |
用于靶向基因疗法的腺相关病毒组合物
|
|
WO2020101042A1
(en)
|
2018-11-16 |
2020-05-22 |
Astellas Pharma Inc. |
Method for treating muscular dystrophy by targeting utrophin gene
|
|
EP3947700A4
(en)
|
2019-04-01 |
2023-01-04 |
Tenaya Therapeutics, Inc. |
Adeno-associated virus with engineered capsid
|
|
EP4028064A1
(en)
*
|
2019-09-12 |
2022-07-20 |
The Broad Institute, Inc. |
Engineered adeno-associated virus capsids
|
|
JP7651562B2
(ja)
*
|
2019-09-19 |
2025-03-26 |
ジェネトン |
Ｆｋｒｐの心毒性を軽減する遺伝子治療発現系
|
|
TWI897882B
(zh)
*
|
2019-09-20 |
2025-09-21 |
英商Ｕｃｌ商業有限責任公司 |
右心室心律失常性心肌病之基因療法組合物及治療
|
|
EP4041755A4
(en)
*
|
2019-10-10 |
2023-10-25 |
Solid Biosciences Inc. |
Modified aav capsids and uses thereof
|
|
AU2020368539A1
(en)
|
2019-10-16 |
2022-04-28 |
Massachusetts Institute Of Technology |
Engineered muscle targeting compositions
|
|
JP2023523573A
(ja)
|
2020-04-14 |
2023-06-06 |
ジェネトン |
酸性セラミダーゼ欠乏症を処置するためのベクター
|
|
US12552838B2
(en)
|
2020-04-20 |
2026-02-17 |
Tenaya Therapeutics, Inc. |
Adeno-associated virus with engineered capsid
|
|
US20230173102A1
(en)
*
|
2020-04-28 |
2023-06-08 |
Genethon |
Use of a Synthetic AAV Capsid for Gene Therapy of Muscle and Central Nervous System Disorders
|
|
EP4126912A4
(en)
*
|
2020-05-05 |
2024-04-24 |
Duke University |
COMPOSITIONS AND METHODS FOR FORMING AND SECRETING EXTRACELLULAR VESILES AND AAV PARTICLES
|
|
WO2021230385A1
(en)
|
2020-05-15 |
2021-11-18 |
Astellas Pharma Inc. |
Method for treating muscular dystrophy by targeting utrophin gene
|
|
US20230159949A1
(en)
*
|
2020-07-22 |
2023-05-25 |
The Broad Institute, Inc. |
Engineered muscle targeting compositions
|
|
KR20230053591A
(ko)
*
|
2020-07-22 |
2023-04-21 |
더 브로드 인스티튜트, 인코퍼레이티드 |
조작된 근육 표적화 조성물
|
|
KR20230042468A
(ko)
*
|
2020-08-05 |
2023-03-28 |
스페이스크래프트 세븐, 엘엘씨 |
Csrp3 (시스테인 및 글리신 풍부 단백질 3) 유전자 요법
|
|
KR20230043869A
(ko)
|
2020-08-07 |
2023-03-31 |
스페이스크래프트 세븐, 엘엘씨 |
Aav 벡터를 사용한 플라코필린-2(pkp2) 유전자 요법
|
|
EP4421179A3
(en)
|
2020-09-10 |
2024-12-18 |
Genethon |
Peptide-modified aav capsid
|
|
CN113754727B
(zh)
*
|
2020-09-30 |
2022-07-12 |
广州派真生物技术有限公司 |
腺相关病毒突变体及其应用
|
|
BR112023006305A2
(pt)
*
|
2020-10-09 |
2023-05-09 |
Tenaya Therapeutics Inc |
Métodos e composições de terapia gênica com placofilina-2
|
|
US11781156B2
(en)
|
2020-10-09 |
2023-10-10 |
Tenaya Therapeutics, Inc. |
Plakophillin-2 gene therapy methods and compositions
|
|
AU2021378075B2
(en)
|
2020-11-11 |
2025-03-27 |
Borea Therapeutics S.R.L. |
Modified viral particles for gene therapy
|
|
WO2022114243A1
(en)
*
|
2020-11-25 |
2022-06-02 |
Astellas Pharma Inc. |
Method for treating muscular dystrophy by targeting dmpk gene
|
|
US20240115734A1
(en)
*
|
2021-02-09 |
2024-04-11 |
Affinia Therapeutics Inc. |
Recombinant aavs with improved tropism and specificity
|
|
CN113480615B
(zh)
*
|
2021-07-30 |
2022-05-31 |
上海信致医药科技有限公司 |
高视网膜亲和性的新型腺相关病毒衣壳蛋白及其应用
|
|
CN113563430B
(zh)
*
|
2021-07-30 |
2022-05-31 |
上海信致医药科技有限公司 |
用于治疗眼部疾病的基因递送系统及其应用
|
|
WO2023060113A1
(en)
|
2021-10-05 |
2023-04-13 |
Regenxbio Inc. |
Compositions and methods for recombinant aav production
|
|
CN118202060A
(zh)
|
2021-10-05 |
2024-06-14 |
再生生物股份有限公司 |
用于重组aav生产的组合物和方法
|
|
KR20240095539A
(ko)
|
2021-10-08 |
2024-06-25 |
디노 테라퓨틱스, 인코포레이티드 |
캡시드 변이체 및 이의 사용 방법
|
|
AU2022420596A1
(en)
*
|
2021-12-21 |
2024-07-11 |
Research Institute At Nationwide Children's Hospital |
Materials and methods for the treatment of limb girdle muscular dystrophy
|
|
CN114516901B
(zh)
*
|
2022-03-11 |
2023-01-17 |
上海勉亦生物科技有限公司 |
一种神经系统高亲和性的aav载体及其应用
|
|
EP4493702A4
(en)
*
|
2022-03-18 |
2026-04-01 |
Univ Florida |
METHODS AND COMPOSITIONS FOR TREATING TNNT2-RELATED CARDIOMYOPATHY WITH A VIRAL VECTOR
|
|
WO2023196862A1
(en)
|
2022-04-06 |
2023-10-12 |
Genzyme Corporation |
Targeted gene therapy for dm-1 myotonic dystrophy
|
|
WO2023198828A1
(en)
|
2022-04-13 |
2023-10-19 |
Universitat Autònoma De Barcelona |
Treatment of neuromuscular diseases via gene therapy that expresses klotho protein
|
|
EP4269426A1
(en)
*
|
2022-04-29 |
2023-11-01 |
Ospedale San Raffaele S.r.l. |
Gene therapy
|
|
ES3057171T3
(en)
|
2022-06-10 |
2026-02-26 |
Genethon |
Peptide-modified aav capsid with enhanced muscle transduction efficiency
|
|
WO2024191778A1
(en)
|
2023-03-10 |
2024-09-19 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
EP4677073A1
(en)
|
2023-03-10 |
2026-01-14 |
Genethon |
Induction of immune tolerance by aav vector comprising the combination of a liver detargeted capsid and a tandem liver-muscle specific promoter
|
|
EP4680741A2
(en)
|
2023-03-15 |
2026-01-21 |
RegenxBio Inc. |
Exon skipping gene therapy constructs, vectors and uses thereof
|
|
US20240384271A1
(en)
|
2023-04-05 |
2024-11-21 |
Genzyme Corporation |
Targeted gene therapy for dm-1 myotonic dystrophy
|
|
WO2024238807A2
(en)
|
2023-05-16 |
2024-11-21 |
Affinia Therapeutics Inc. |
Recombinant aavs with improved tropism and specificity
|
|
CN121712809A
(zh)
|
2023-07-03 |
2026-03-20 |
Ucb生物制药有限责任公司 |
工程化的aav衣壳蛋白
|
|
CN116970041B
(zh)
*
|
2023-07-21 |
2024-02-09 |
广州派真生物技术有限公司 |
腺相关病毒突变体及其应用
|
|
AU2024332181A1
(en)
|
2023-08-31 |
2026-02-12 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2025133247A1
(en)
|
2023-12-21 |
2025-06-26 |
Genethon |
Methods for aav vector re-administration
|
|
TW202545971A
(zh)
|
2024-02-08 |
2025-12-01 |
美商戴諾治療公司 |
殼體多肽及其使用方法
|
|
WO2025232917A1
(en)
*
|
2024-05-10 |
2025-11-13 |
Hangzhou Jiayin Biotech Ltd. |
Novel liver detargeted aav variants and uses thereof
|
|
WO2026006341A1
(en)
|
2024-06-24 |
2026-01-02 |
Regenxbio Inc. |
Microdystrophin gene therapy administration for treatment of dystrophinopathies
|
|
WO2026017727A1
(en)
|
2024-07-16 |
2026-01-22 |
Genethon |
Alternative barcoding method to assess transduction efficiency of aav vectors
|
|
WO2026064428A2
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2026064442A2
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2026064444A1
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|